Violence in older people with mental illness
... that violent offences were strongly associated with paranoia at the time of the offence. Perhaps unsurprisingly, active symptoms at the time of the offence were more predictive of a violent offence than was a previous history of mental disorder. In their study of elderly psychiatric patients who had ...
... that violent offences were strongly associated with paranoia at the time of the offence. Perhaps unsurprisingly, active symptoms at the time of the offence were more predictive of a violent offence than was a previous history of mental disorder. In their study of elderly psychiatric patients who had ...
Treatment Guidelines for Psychotic Disorders
... planning and service delivery for patients with primary psychotic disorders. It may also assist clinicians treating patients who have some psychotic symptoms or functional impairment similar to patients with primary psychotic disorders, but where etiology is uncertain. The treatment guideline is not ...
... planning and service delivery for patients with primary psychotic disorders. It may also assist clinicians treating patients who have some psychotic symptoms or functional impairment similar to patients with primary psychotic disorders, but where etiology is uncertain. The treatment guideline is not ...
Treating generalised anxiety disorder
... doses of 150-400mg seem to be associated with rates that are not statistically significantly different from placebo. The longitudinal course of many cases of GAD suggests that relapse prevention is rational. Paroxetine, escitalopram, duloxetine, quetiapine and pregabalin reduce the risk of relapse. ...
... doses of 150-400mg seem to be associated with rates that are not statistically significantly different from placebo. The longitudinal course of many cases of GAD suggests that relapse prevention is rational. Paroxetine, escitalopram, duloxetine, quetiapine and pregabalin reduce the risk of relapse. ...
Part I -- bipolar basics
... change in the sensitivity of the receptors on nerve cells may be the issue ...
... change in the sensitivity of the receptors on nerve cells may be the issue ...
Pediatric Bipolar Disorder
... population samples could be expected to have a manic disorder. 20-30% of children who have psychiatric problems are referred for or receive psychiatric help. Therefore, the typical clinician is likely to have a low rate of exposure to youths with mania, which makes it difficult to form a template of ...
... population samples could be expected to have a manic disorder. 20-30% of children who have psychiatric problems are referred for or receive psychiatric help. Therefore, the typical clinician is likely to have a low rate of exposure to youths with mania, which makes it difficult to form a template of ...
An Overview of Mood Disorders/Depression
... conditions bring to daily living. Children with autism spectrum disorder are at higher risk for major mood disorders. Serious medical conditions such as heart problems and cancer can also contribute to depression, partly because of the physical weakness and stress they bring on. People who have had ...
... conditions bring to daily living. Children with autism spectrum disorder are at higher risk for major mood disorders. Serious medical conditions such as heart problems and cancer can also contribute to depression, partly because of the physical weakness and stress they bring on. People who have had ...
Mood (affective) disorders (F30-F39)
... mild and severe depressive disorders; in severe disorders they are as effective as ECT, but they take 2 weeks or more to achieve an effect while ECT has a more rapid action. Newer Antidepressant Drugs. Many antidepressant drugs have been developed since imipramine and amitriptyline were first introd ...
... mild and severe depressive disorders; in severe disorders they are as effective as ECT, but they take 2 weeks or more to achieve an effect while ECT has a more rapid action. Newer Antidepressant Drugs. Many antidepressant drugs have been developed since imipramine and amitriptyline were first introd ...
Lithium and valproate in manic and mixed states: a naturalistic
... 41 patients (54.7%) were treated with the combination of lithium and valproate. The daily dose was of 664 ± 165 mg/day for lithium carbonate (range: 4501200 mg/day) and 822 ± 294 mg/day for sodium valproate (range: 500-1250 mg/day). The mean serum lithium level (mean ± SD; mEq/l) was 0.50 ...
... 41 patients (54.7%) were treated with the combination of lithium and valproate. The daily dose was of 664 ± 165 mg/day for lithium carbonate (range: 4501200 mg/day) and 822 ± 294 mg/day for sodium valproate (range: 500-1250 mg/day). The mean serum lithium level (mean ± SD; mEq/l) was 0.50 ...
Revisiting unitary psychosis, from nosotaxis to
... nosography is the part of nosology that deals with the classification and description of diseases. However, it would be more accurate to say that nosography deals with description of disease, while nosotaxis deals with classification, although “nosotaxis” does not appear in the aforementioned dictio ...
... nosography is the part of nosology that deals with the classification and description of diseases. However, it would be more accurate to say that nosography deals with description of disease, while nosotaxis deals with classification, although “nosotaxis” does not appear in the aforementioned dictio ...
Diagnostic Criteria for Schizophrenia - Sn-dd
... 2. Significant negative outcomes related to substance abuse: 1) Clinical relapse & rehospitalization 2) Demoralization 3) Family stress 4) Violent behavior ...
... 2. Significant negative outcomes related to substance abuse: 1) Clinical relapse & rehospitalization 2) Demoralization 3) Family stress 4) Violent behavior ...
Please keep track of any disorders discussed that you would like to
... observations of others – Markedly diminished interest or pleasure in (almost) all activities – Significant weight loss or weight gain not caused by an intentional change in diet; decrease/increase in appetite • Children: failure to meet growth milestones ...
... observations of others – Markedly diminished interest or pleasure in (almost) all activities – Significant weight loss or weight gain not caused by an intentional change in diet; decrease/increase in appetite • Children: failure to meet growth milestones ...
Schizoaffective Disorder in Life
... Methods: A systematic search for studies simultaneously compared all three diagnoses with direct regard to their demographic, clinical, psychometric, and biological parameters, using a comparison of heterogeneity from the studies measured by standard deviation. ...
... Methods: A systematic search for studies simultaneously compared all three diagnoses with direct regard to their demographic, clinical, psychometric, and biological parameters, using a comparison of heterogeneity from the studies measured by standard deviation. ...
PCS_presentation - Vanderbilt University School of Medicine
... • Family history mood/psych disorder • Delayed symptoms ...
... • Family history mood/psych disorder • Delayed symptoms ...
Basic Statistics for the Behavioral Sciences
... – Circumscribed loss of memory – Inability to transfer information into long-term ...
... – Circumscribed loss of memory – Inability to transfer information into long-term ...
Antipsychotic Medication
... diabetes, and dyslipidemia, often resulting in cardiovascular disease ...
... diabetes, and dyslipidemia, often resulting in cardiovascular disease ...
DSM-IV-TR in Action Powerpoint
... Anorexia Nervosa: intense fear of gaining weight, usually underweight, disturbance in body image, won’t eat, overexercise, often have amenorrhea, refusal to maintain minimum normal body weight, resistance to treatment with strong denial, onset during late adolescence (12-18) and can go into 30s, ind ...
... Anorexia Nervosa: intense fear of gaining weight, usually underweight, disturbance in body image, won’t eat, overexercise, often have amenorrhea, refusal to maintain minimum normal body weight, resistance to treatment with strong denial, onset during late adolescence (12-18) and can go into 30s, ind ...
What It Feels Like to Live with Bipolar Disorder
... try not to confuse my experience having a mood disorder with expertise, and this is an area of disagreement among doctors, so I will tread cautiously. Bipolar disorder is known to have a strong genetic component—so it’s likely that my genes predisposed me to have a mood disorder—but until I was trea ...
... try not to confuse my experience having a mood disorder with expertise, and this is an area of disagreement among doctors, so I will tread cautiously. Bipolar disorder is known to have a strong genetic component—so it’s likely that my genes predisposed me to have a mood disorder—but until I was trea ...
Mood disorders: pearls of wisdom from a lifetime of observation
... view, correct statistical analysis of trial data shows that antidepressants start to induce change within the first 12 days of their administration and do not take a number of weeks to have an effect as has been assumed. That has implications for treatment. ...
... view, correct statistical analysis of trial data shows that antidepressants start to induce change within the first 12 days of their administration and do not take a number of weeks to have an effect as has been assumed. That has implications for treatment. ...
Depressive and Bipolar Disorders
... • Typically lose interest in activities & relationships and take pleasure in nothing • Despite best efforts, everything from conversation to bathing is an unbearable, exhausting effort • Often exaggerated feelings of inadequacy, worthlessness, hopelessness, or guilt ...
... • Typically lose interest in activities & relationships and take pleasure in nothing • Despite best efforts, everything from conversation to bathing is an unbearable, exhausting effort • Often exaggerated feelings of inadequacy, worthlessness, hopelessness, or guilt ...
NEI`s Master Psychopharmacology Program Study Guide: Bipolar
... **These resources do not count toward the requirements of the Master Psychopharmacology Program and are merely listed here as useful resources for additional study. http://cdn.neiglobal.com/content/mpp/studyguide/studyguide_bipolar.pdf ...
... **These resources do not count toward the requirements of the Master Psychopharmacology Program and are merely listed here as useful resources for additional study. http://cdn.neiglobal.com/content/mpp/studyguide/studyguide_bipolar.pdf ...
Drug-induced hypo- and hyperprolactinemia: mechanisms, clinical
... Prolactin itself exists in an interrelationship of feedback control with its own secretion/concentration in the biophase. The inhibition of secretion is triggered by activation of hypothalamic dopamine neurons or directly, by acting on the lactotroph cells [5]. The cholinergic system in the hypophys ...
... Prolactin itself exists in an interrelationship of feedback control with its own secretion/concentration in the biophase. The inhibition of secretion is triggered by activation of hypothalamic dopamine neurons or directly, by acting on the lactotroph cells [5]. The cholinergic system in the hypophys ...
Invega PI
... caused a slight increase in the free fraction of paliperidone at 50 ng/mL. These changes are not expected to be of clinical significance. Metabolism and Elimination: One week following administration of a single oral dose of 1 mg immediate-release 14C-paliperidone, 59% (range 51% - 67%) of the dose ...
... caused a slight increase in the free fraction of paliperidone at 50 ng/mL. These changes are not expected to be of clinical significance. Metabolism and Elimination: One week following administration of a single oral dose of 1 mg immediate-release 14C-paliperidone, 59% (range 51% - 67%) of the dose ...
Bipolar Disorder
... Anticonvulsants - these long-term stabilizing drugs are sometimes prescribed to treat mania episodes. Although primarily used for the treatment of epilepsy, anticonvulsants are often effective when treating bipolar disorder. Examples include valproate, carbamazepine, and lamotrigine. Doctors someti ...
... Anticonvulsants - these long-term stabilizing drugs are sometimes prescribed to treat mania episodes. Although primarily used for the treatment of epilepsy, anticonvulsants are often effective when treating bipolar disorder. Examples include valproate, carbamazepine, and lamotrigine. Doctors someti ...
Antipsychotic
Antipsychotics (also known as neuroleptics or major tranquilizers) are a class of psychiatric medication primarily used to manage psychosis (including delusions, hallucinations, or disordered thought), in particular in schizophrenia and bipolar disorder, and are increasingly being used in the management of non-psychotic disorders (ATC code N05A). The word neuroleptic originates from the Greek word νεῦρον neuron (""nerve"") and λῆψις lepsis (""seizure"", ""fit"", ""occupation"").First-generation antipsychotics, known as typical antipsychotics, were discovered in the 1950s. Most second-generation drugs, known as atypical antipsychotics, have been developed more recently, although the first atypical antipsychotic, clozapine, was discovered in the 1950s and introduced clinically in the 1970s. Both generations of medication tend to block receptors in the brain's dopamine pathways, but atypicals tend to act on serotonin receptors as well.Antipsychotics are more effective than placebo in treating symptoms of psychosis, but some people do not respond fully or even partly to treatment. Their use is associated with significant side effects, most notably movement disorders and weight gain.